ID: ALA3527301

Max Phase: Preclinical

Molecular Formula: C14H12F2S2

Molecular Weight: 282.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Fc1ccc(CSSCc2ccc(F)cc2)cc1

Standard InChI:  InChI=1S/C14H12F2S2/c15-13-5-1-11(2-6-13)9-17-18-10-12-3-7-14(16)8-4-12/h1-8H,9-10H2

Standard InChI Key:  TVCLHSCUNDIOEP-UHFFFAOYSA-N

Associated Targets(non-human)

Whole blood 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 282.38Molecular Weight (Monoisotopic): 282.0348AlogP: 5.05#Rotatable Bonds: 5
Polar Surface Area: 0.00Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 1HBA (Lipinski): 0HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.03CX LogD: 5.03
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.56Np Likeness Score: -0.56

References

1. Pan H, Gu L, Sun S, Chen Z, Zhou H, Zeng S, Jiang H..  (2013)  Metabolism of bis(4-fluorobenzyl)trisulfide and its formation of hemoglobin adduct in rat erythrocytes.,  41  (5): [PMID:23439662] [10.1124/dmd.112.048801]

Source